Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures

Clinical trial NCT00771927 · COMPLETED

Trial details

NCT number: NCT00771927
Sponsor: UCB Pharma
Status: COMPLETED
Study type: OBSERVATIONAL

Epilepsies, Partial

Start date: 2008-10-01
Primary completion: 2012-03-01
Enrollment: 1005

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.